Literature DB >> 7392542

Comparison of indicators for dane particles.

G Hess, W Arnold, K H Meyer zum Buschenfelde.   

Abstract

The Dane particle is-because of its characteristics--believed to be the complete hepatitis-B-virus. Sera containing high numbers of Dane particles were shown to be highly infectious. In the present study we related the HBeAg-, the HBsAg- and the anti-HBc titer to the level of DNA polymerase activity measured in 20 fold Dane particle concentrates. The data obtained indicate that the HBeAg concentration gives a semiquantitative estimate on the number of circulating Dane particles. Mean DNA polymerase activity was found to increase with HBsAg concentration and is therefore also of value-if determined in a HBeAg positive serum- for quantitation of Dane particles. The anti-HBc titer was found to be unrelated to the number of circulating Dane particles.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7392542     DOI： 10.1007/bf01477280

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  23 in total

1.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

2.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

3.  Structure of hepatitis B Dane particle DNA before and after the Dane particle DNA polymerase reaction.

Authors:  J F Hruska; D A Clayton; J L Rubenstein; W S Robinson
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

4.  Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays.

Authors:  I K Mushahwar; L R Overby; G Frosner; F Deinhardt; C M Ling
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

5.  Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with type B hepatitis.

Authors:  W Arnold; G Hess; H Kawakami; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15

6.  Letter: Infectivity of serum containing HBsAg and antibody to e antigen.

Authors:  K R Berquist; J E Maynard; B L Murphy
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

7.  A new antigen complex co-occurring with Australia antigen.

Authors:  L O Magnius; A Espmark
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

8.  Hepatitis B-specific DNA polymerase activity during post-transfusion hepatitis.

Authors:  P M Kaplan; J L Gerin; H J Alter
Journal:  Nature       Date:  1974-06-21       Impact factor: 49.962

9.  Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.

Authors:  H J Alter; L B Seeff; P M Kaplan; V J McAuliffe; E C Wright; J L Gerin; R H Purcell; P V Holland; H J Zimmerman
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

10.  Hepatitis B virus markers among family contacts of asymptomatic HBsAg carriers.

Authors:  G Hess; M Born; H Dormeyer; B Zöller; W Arnold; J Knolle
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423
View more
  2 in total

1.  The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study.

Authors:  F Fiaccadori; S David; G Faggion; N Feriani; C Ferrari; V Franco; T Giuberti; C Grutta D'Auria; G La Greca; G Magnani
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

2.  Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection.

Authors:  E G Lindenschmidt; C F Granato; C Salefsky; R Laufs; H Henning
Journal:  Klin Wochenschr       Date:  1984-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.